Nicotinamide ribose
Pro Research Analysisby 
Searched over 200M research papers for "nicotinamide ribose"
Consensus Meter
Nicotinamide Ribose: Enhancing NAD+ Metabolism and Potential Therapeutic Benefits
Introduction to Nicotinamide Ribose and NAD+ Metabolism
Nicotinamide ribose (NR) is a form of vitamin B3 and a precursor to nicotinamide adenine dinucleotide (NAD+), a crucial coenzyme in cellular metabolism. NAD+ plays a vital role in various biological processes, including energy production, DNA repair, and cell signaling. The decline of NAD+ levels is associated with aging and several diseases, making NR a promising candidate for therapeutic interventions.
Increasing NAD+ Levels with Nicotinamide Ribose
Recent studies have demonstrated the efficacy of NR in boosting NAD+ levels. A pilot clinical trial showed that a combination of nicotinamide and D-ribose (RiaGev) significantly increased the NAD+ metabolome in healthy middle-aged adults. This increase was particularly notable for NADP+, which rose by 27% compared to the placebo group. Additionally, the supplementation improved insulin sensitivity, reduced blood glucose levels, and decreased waking salivary cortisol, indicating potential benefits for metabolic health and stress reduction.
Mechanisms of Action: NAD+ and Sirtuins
NR serves as a substrate for NAD+-consuming enzymes, including sirtuins, which are involved in gene silencing, DNA repair, and metabolism. Sirtuins, such as Sir2, utilize NAD+ to deacetylate proteins, producing nicotinamide and ADP-ribose as byproducts . This process is crucial for maintaining cellular homeostasis and has implications for longevity and disease prevention.
Therapeutic Potential in Neurodegenerative Diseases
Nicotinamide, a form of vitamin B3, has shown promise in treating neurodegenerative diseases like Alzheimer's Disease (AD). It acts as an inhibitor of Poly [ADP-ribose] polymerase 1 (PARP-1), an enzyme involved in DNA repair and cell death regulation. By inhibiting PARP-1, nicotinamide can prevent NAD+ depletion and reduce neuroinflammation, potentially offering neuroprotective effects. This suggests that NR could be a valuable adjunctive therapy for early-stage AD by enhancing NAD+ availability and inhibiting harmful enzymatic activity.
Cancer Cachexia and Muscle Atrophy
NR has also been investigated for its role in mitigating cancer cachexia, a condition characterized by severe weight loss and muscle atrophy in cancer patients. In a mouse model, preemptive administration of NR significantly attenuated cancer cachexia by inhibiting muscle-specific ubiquitin-proteasome ligases and reducing inflammatory markers like tumor necrosis factor-alpha and interleukin-6. This highlights NR's potential in preserving muscle mass and improving quality of life in cancer patients.
Implications for Metabolic Health
The ability of NR to enhance NAD+ levels has broader implications for metabolic health. Increased NAD+ can improve mitochondrial function, which is crucial for energy production and metabolic regulation. Studies have shown that NR supplementation can lead to increased levels of NAD+ and its related metabolites, which are essential for maintaining metabolic homeostasis.
Conclusion
Nicotinamide ribose is a promising compound for enhancing NAD+ metabolism and offering therapeutic benefits across various health conditions. Its ability to increase NAD+ levels, improve metabolic health, and provide neuroprotective effects makes it a valuable candidate for further research and potential clinical applications. As our understanding of NAD+ metabolism and its role in health and disease continues to grow, NR may become a key component in strategies aimed at promoting longevity and combating age-related diseases.
Sources and full results
Most relevant research papers on this topic